STAT+: Pharmalittle: FDA panel recommends Moderna Covid booster shots; Biden eyes Califf as FDA commish

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda largely involves spending chunks of time with our shortest person, rambling about back roads, and enjoying the great outdoors. And what about you? This is a fine time to visit apple orchards and pumpkin patches. You could double-check that you are registered to vote or boost the economy by purchasing some winter gear. Maybe you could convince someone to get vaccinated. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

A U.S. Food and Drug Administration advisory panel voted unanimously in favor of authorizing booster shots of the Moderna (MRNA) Covid-19 vaccine to people 65 and older, those 18 to 64 with risk factors for severe Covid-19, and those whose jobs put them at high risk for serious complications of Covid-19, such as health care workers, STAT writes. After hours of deliberation, the panel voted 19-to-0 that the Moderna booster should be authorized for these groups at least six months after receiving their second dose. The panel also discussed at what point boosters should be recommended to all adults over 18, saying that at this point it is far too soon to consider the matter.

Continue to STAT+ to read the full story…

STAT+: Pharmalittle: FDA panel recommends Moderna Covid booster shots; Biden eyes Califf as FDA commish

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top